Get latest articles and stories on Business at LatestLY. SELUTION SLR™, MedAlliance s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions. Business News | MedAlliance SELUTION SLR is the First DEB to Receive Coronary De Novo IDE Approval, Its Fourth FDA IDE DEB Approval.
AHA News: How to Lower Heart Disease and Breast Cancer Risk at the Same Time kxly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kxly.com Daily Mail and Mail on Sunday newspapers.
AHA News: How to Lower Heart Disease and Breast Cancer Risk at the Same Time kentuckynewera.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kentuckynewera.com Daily Mail and Mail on Sunday newspapers.
AHA News: How to Lower Heart Disease and Breast Cancer Risk at the Same Time franklinfavorite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from franklinfavorite.com Daily Mail and Mail on Sunday newspapers.